Keywords: cephalon, 1st-qtr, sales, up, 215m, usa, seen
Cephalon's 1st-qtr sales up 49% to $215M
Article | 10 May 2004
The USA's Cephalon has seen its first-quarter revenue jump 49% to $215.0 million from $144.7 million for the year-ago period. Diluted earnings per ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
